Navigation Links
VIVUS Provides Regulatory Update on QNEXA NDA
Date:1/21/2011

MOUNTAIN VIEW, Calif., Jan. 21, 2011 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity.  The meeting occurred on January 19th at the FDA's offices in Maryland and was attended by senior members of the FDA and VIVUS' management and consultants.  At this meeting the FDA requested that VIVUS assess the feasibility of analyzing existing healthcare databases to determine the historical incidence of oral cleft in offspring of women treated with topiramate for migraine prophylaxis (100 mg).

Based on discussions at the meeting, VIVUS believes the FDA's additional request stems from two published reports which cited two oral clefts in the UK Epilepsy and Pregnancy Register (Hunt et al., July 2008) and four, including two isolated cleft lips, from the North American AED Pregnancy Registry (Hernandez-Diaz et al., June 2010).  In the QNEXA® studies, which included 15 births from women exposed to QNEXA® or topiramate, there were no reports of any fetal malformations. The timing of the planned resubmission of the QNEXA® NDA will be determined after agreement with the FDA is reached on the feasibility assessment.  VIVUS anticipates continued dialog with the FDA on the planned resubmission of the QNEXA® NDA.

About QNEXA® Controlled Release Capsules QNEXA® [kyoo-nek-suh] is an investigational drug being developed to address weight loss, type 2 diabetes and obstructive sleep apnea. QNEXA® is a once-a-day, proprietary, oral, controlled-release formulation of low-dose phentermine and topiramate, which together decrease appetite and increase satiety (the sense of feeling full), the two main mechanisms that impact eating behavior. In phase 2
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VIVUS to Present at the 2011 JP Morgan Healthcare Conference
2. VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
3. VIVUS to Present at Two Upcoming Investor Conferences
4. VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results
5. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
6. VIVUS Announces Sale of MUSE Assets to Meda
7. VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
8. VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results
9. VIVUS to Present at Lazard Capital Markets Healthcare Conference
10. VIVUS Announces Promotion of Peter Tam to President
11. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 2015 ViiV Healthcare, Aurobindo Pharma, ... today that Aurobindo Pharma has submitted an Abbreviated New ... to the Food and Drug Administration (FDA), for the ... a generic version of dolutegravir, less than two years ... the United States . ...
(Date:5/26/2015)... 26, 2015  LabStyle Innovations Corp. (DRIO), ... announced today that in partnership with ... Healthcare, it has launched  the comprehensive Dario™ ... advanced Telecare unit (MOMA). The Dario™ is ... enables remote treatment for diabetes aiming to ...
(Date:5/26/2015)... May 26, 2015  Respiratory Motion, Inc. – ... Annual Meeting of the Japanese Society of Anesthesiologists ... respiration in hospitals miss critical early indicators of ... The findings conclude that respiratory volume monitoring using ... more consistently protects patients than traditional capnography and ...
Breaking Medicine Technology:ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 3LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5
... DIEGO, Feb. 8, 2011 Anadys Pharmaceuticals, Inc. (Nasdaq: ... the 13th Annual Bio CEO & Investor Conference on Tuesday, ...  The conference is being held at the Waldorf-Astoria Hotel in ... Officer of Anadys, will provide an overview of Anadys and ...
... District of Columbia Patients Cooperative (DCPC), a taxable non-profit corporation ... affordable medical "marijuana" to qualifying DC patients will host a ... marijuana program.  The public meeting is open to members of ... at 7:00 pm in Pierce Hall at All Souls Unitarian ...
Cached Medicine Technology:Anadys Pharmaceuticals to Present at the Bio CEO & Investor Conference 2February 10 Town Hall Meeting to Explain DC's New Medical Marijuana Program 2
(Date:5/26/2015)... It was an evening befitting the largest, ... Wednesday, May 13, The Denver Foundation marked 90 years ... community-based giving with its Annual Celebration, held at the ... the event celebrated the donors, leaders, grantees, and volunteers ... for good. , “If your organization, neighborhood group, or ...
(Date:5/26/2015)... 2015 Relias Learning , the ... health and human services market, announces expansion of their ... strong attendance and participation in 2014, they will double ... annual user conference an exciting new facelift. , ... together and discuss best practices, share their expertise, provide ...
(Date:5/26/2015)... 26, 2015 CIO Review has chosen ... Pharma and Life Sciences Technology Solution Providers. The positioning is ... compliant solution which is applicable across the entire security spectrum ... for broad adoption. , “SIGNiX has been on our ... Pharma and Life Sciences Technology space, and we are happy ...
(Date:5/26/2015)... Fredericton, New Brunswick (PRWEB) May 26, 2015 ... , announce the successful upgrade of the DMi ... software. This version was the first in Indosoft's contact ... included API improvements, added screen support for such trunk ... admin screens, improved lead management, and included upgrades to ...
(Date:5/26/2015)... York, USA (PRWEB) May 26, 2015 ... the site, AnyTranscription has undertaken a comprehensive upgrade of ... improvement in user experience. To thank users for their ... launching this five minute trial transcription service ... weeks from May 26 to June 9 this year. ...
Breaking Medicine News(10 mins):Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 2Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 3Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 3
... higher rates of chronic disease than others, according to ... Health in conjunction with its Office of Women's ... report, which examined the relationship between ethnicity and women's ... from 8,600 residents randomly surveyed by telephone in 2005. ...
... Together, they form a difficult pair to beat . ... of Ohio University College of Osteopathic Medicine (OU-COM) and ... to the double-edged problem. Program ACTIVE (Appalachians Coming Together ... study to test the effectiveness of a combination of ...
... region already ravaged by poverty and inter-tribal tensions. ... against HIV/AIDS there terribly exhausting, almost fruitless, yet ... reduce the continuing, extraordinary HIV prevalence in Botswana and ... enforce women's legal rights," Karen Leiter, lead investigator ...
... the Middle East, said doctors from UAE who met in ... . ,However, the medical experts agreed that the ... longer, WAM news agency reported. ,The good news ... that breast cancer cases (in UAE) are being caught much ...
... Medicine and the Veterans Affairs Palo Alto Health Care System ... new- born deaths between 1991 and 2000 in California, could ... if they had been born in different hospitals. Risky deliveries ... would afford the best chance of survival for newborns, who ...
... of Advanced Nursing reports that many socially disadvantaged UK residents ... . ,A research across London by TB specialists ... trying to halt the spread of the disease. ... last 10 years and London is no exception" says lead ...
Cached Medicine News:Health News:Minority Women in LA County Have Higher Rates of Chronic Disease Than Whites 2Health News:Study Tests Depression Treatment for Diabetes Patients 2Health News:Study Tests Depression Treatment for Diabetes Patients 3Health News:Cultural Bias Against Women Hampering Fight Against AIDS in Africa 2Health News:Low Weight Newborns at Greater Risk in Community Hospitals 2Health News:Low Weight Newborns at Greater Risk in Community Hospitals 3Health News:TB Patients in Marginalised Groups Need Social Support for Effective Medical Treatment 2
... a highly sensitive DR system. It features ... it is designed for most general radiographic ... multiple wall stand and table configurations. , ... efficiently produces detailed patient images with reduced ...
... to remove bone cement speedily and efficiently. , ... cement at the point of contact, allowing it ... feature of the apparatus is its ability to ... to the operator instantly. Probe position can thus ...
Provides stable positioning of the knee during surgery....
... processes blood collected from a surgical ... cells for return to a patient ... achieved with only one kit and ... coupled with sophisticated software, provides an ...
Medicine Products: